title: Administrative detention of drugs intended for human or animal use. Final rule.
abstract: The Food and Drug Administration (FDA or the Agency) is implementing administrative detention authority with respect to drugs intended for human or animal use as authorized by amendments made to the Federal Food, Drug, and Cosmetic Act (the FD&C Act) by the Food and Drug Administration Safety and Innovation Act (FDASIA). FDA's administrative detention authority with respect to drugs allows FDA to better protect the integrity of the drug supply chain. Specifically, FDA is able to administratively detain drugs encountered during an inspection that an authorized FDA representative conducting an inspection has reason to believe are adulterated or misbranded. This authority is intended to protect the public by preventing distribution or subsequent use of drugs encountered during inspections that are believed to be adulterated or misbranded, until FDA has had time to consider what action it should take concerning the drugs, and to initiate legal action, if appropriate.
mesh_terms: D000818:Animals; D004340:Drug Contamination / Q000331:legislation & jurisprudence* / Q000517:prevention & control; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D007880:Legislation, Drug; D004364:Pharmaceutical Preparations / Q000600:supply & distribution; D014481:United States; D019155:Veterinary Drugs / Q000600:supply & distribution
chemical_list: D004364:Pharmaceutical Preparations; D019155:Veterinary Drugs